Endoscopic Treatment for Early Foregut Neuroendocrine Tumors

• Published in: Clinical endoscopy Vol. 46; no. 5; pp. 450 - 455
• Main Author: Park, Moo In
• Format: Journal Article
• Language: English
• Published: Korea (South) The Korean Society of Gastrointestinal Endoscopy 01.09.2013; 대한소화기내시경학회
• Subjects: Special Issue of IDEN 2013; 내과학; Stomach; Duodenum; Endoscopic treatment; Neuroendocrine tumors
• ISSN: 2234-2400; 2234-2443
• DOI: 10.5946/ce.2013.46.5.450

Foregut neuroendocrine tumors (NETs) include those arising in the esophagus, stomach, pancreas, and duodenum and seem to have a broad range of clinical behavior from benign to metastatic. Several factors including the advent of screening endoscopy may be related to increased incidence of gastrointestinal NETs; thus, many foregut NETs are diagnosed at an early stage. Early foregut NETs, such as those of the stomach and duodenum, can be managed with endoscopic treatment because of a low frequency of lymph node and distant metastases. However, controversy continues concerning the optimal management of early foregut NETs due to a lack of controlled prospective studies. Several issues such as indications, technical issues, and outcomes of endoscopic treatment for early foregut NETs are reviewed based on some published studies.